Other OTC - Delayed Quote USD

ContraFect Corporation (CFRXQ)

0.0120 -0.0001 (-0.83%)
At close: May 14 at 3:58 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
30,214.0000
56,889.0000
47,265.0000
34,239.0000
Operating Income
-30,214.0000
-56,889.0000
-47,265.0000
-34,239.0000
Net Non Operating Interest Income Expense
327.0000
81.0000
109.0000
192.0000
Other Income Expense
5,749.0000
-8,345.0000
26,874.0000
5,891.0000
Pretax Income
-24,138.0000
-65,153.0000
-20,282.0000
-28,156.0000
Net Income Common Stockholders
-24,138.0000
-65,153.0000
-20,282.0000
-28,156.0000
Diluted NI Available to Com Stockholders
-24,138.0000
-65,153.0000
-20,282.0000
-28,156.0000
Basic EPS
-15.03
-124.97
-44.12
-98.95
Diluted EPS
-15.03
-124.97
-44.12
-98.95
Basic Average Shares
4,322.1500
521.3590
459.6990
284.5440
Diluted Average Shares
4,322.1500
521.3590
459.6990
284.5440
Total Operating Income as Reported
-30,214.0000
-64,608.0000
-47,265.0000
-34,239.0000
Total Expenses
30,214.0000
56,889.0000
47,265.0000
34,239.0000
Net Income from Continuing & Discontinued Operation
-24,138.0000
-65,153.0000
-20,282.0000
-28,156.0000
Normalized Income
-34,796.0000
-61,621.0000
-47,156.0000
-36,212.0000
Interest Income
327.0000
81.0000
109.0000
192.0000
Net Interest Income
327.0000
81.0000
109.0000
192.0000
EBIT
-30,214.0000
-56,889.0000
-47,265.0000
-34,239.0000
EBITDA
-30,055.0000
-56,735.0000
-47,117.0000
-34,071.0000
Reconciled Depreciation
159.0000
154.0000
148.0000
168.0000
Net Income from Continuing Operation Net Minority Interest
-24,138.0000
-65,153.0000
-20,282.0000
-28,156.0000
Total Unusual Items Excluding Goodwill
10,658.0000
-3,532.0000
26,874.0000
8,056.0000
Total Unusual Items
10,658.0000
-3,532.0000
26,874.0000
8,056.0000
Normalized EBITDA
-40,713.0000
-53,203.0000
-73,991.0000
-42,127.0000
12/31/2020 - 9/12/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CHNXF ChitogenX Inc.
0.0354
0.00%
 
BXRXQ Baudax Bio, Inc.
0.0071
-29.00%
 
RGTPQ RegenETP, Inc.
0.0699
0.00%
 
CUBT Curative Biotechnology, Inc.
0.0216
-11.28%
 
NBRVF Nabriva Therapeutics plc
0.0000
0.00%
 
KRBP Kiromic BioPharma, Inc.
2.6700
+1.91%
 
KA Kineta, Inc.
0.5200
+0.04%
 
INAB IN8bio, Inc.
1.0400
+2.97%
 
NRBO NeuroBo Pharmaceuticals, Inc.
4.1100
+3.79%
 
KTTA Pasithea Therapeutics Corp.
6.65
-3.62%